The US Patent and Trademark Office (USPTO) has issued the US patent covering Cerecor's antitussive, FP01, a unique formulation of memantine hydrochloride. The patent protects composition of lozenge, which provides a dual mechanism of ...
Tags: FP01 Antitussive, USPTO